Elizabeth Phillips, MD
Urology · Sartell, MNNPI 1386871622
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (38.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Endo Pharmaceuticals Inc. at 51.9% of the total. Among urology clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 85 payments — averaging $179.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endo Pharmaceuticals Inc.$8K
- Coloplast$3K
- Boston Scientific$2K
- Medtronic$2K
- C. R. Bard, Inc. & Subsidiaries$165
- Antares Pharma, Inc.$139
- plus $82 from 4 others
What the payments were for
- Consulting fees$5,82038%
- Speaking & faculty fees$8806%
- Travel & lodging$4,70831%
- Food & beverage$3,79025%
- Education$350%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endo Pharmaceuticals Inc. | 18 | $7,904 |
| Coloplast | 26 | $2,902 |
| Boston Scientific | 17 | $2,330 |
| Medtronic | 14 | $1,711 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $165 |
| Antares Pharma, Inc. | 4 | $139 |
| AstraZeneca | 1 | $35 |
| Ambu Inc. | 1 | $18 |
| Axonics, Inc. | 1 | $14 |
| Endo USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XIAFLEX$7,527
- TITAN$2,101
- Solyx SIS System$1,265
- ALTAVIVA$1,144
- GENERAL - THERAPIES$450
- GENERAL ERECTILE DYSFUNCTION$147
- SOLYX BLUE$128
How this compares
$15,233 in reported general payments places this provider in the 90th percentile of 247 urology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 82 | $57,584 |
| Estradiol | 67 | $11,783 |
| Tamsulosin Hcl | 267 | $3,474 |
| ClomidClomiphene Citrate | 13 | $3,159 |
| Finasteride | 152 | $2,234 |
| Trospium Chloride ErTrospium Chloride | 14 | $2,084 |
| Oxybutynin Chloride ErOxybutynin Chloride | 94 | $1,836 |
| Trospium Chloride | 45 | $1,790 |
| Solifenacin Succinate | 79 | $1,319 |
| Testosterone Cypionate | 25 | $752 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 13 | $544 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 13 | $256 |
| Oxybutynin Chloride | 48 | $177 |
| Cephalexin | 26 | $113 |
| Nystatin | 15 | $102 |
Paid to pharmacies, not to this prescriber.
Other urology in Sartell
- Andrew WindspergerSartell$24K
- David YangMankato$298K
- Steven BernsteinEdina$271K
- Ayman SoubraMinneapolis$204K
- Sean ElliottMinneapolis$163K
- Jonathan WarnerRochester$144K
- Steven SiegelWoodbury$140K
- Aaron MilbankWoodbury$97K
- Tobias KohlerRochester$89K
- Joseph MahonEdina$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.